col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


24 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Diabetes and its Complications
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jun―15 A comprehensive analysis of diabetic patient data before and during the COVID-19 pandemic - Lessons from the MÉRY diabetes database (MDD) Zsolt Hermányi, Adrienn Menyhárt, Anna Erzsébet Körei, Ildikó Istenes, Genevieve Arany Lao-kan, Vanda Csiki, et al. (+5)
2 [GO] 2023―Apr―14 Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic Yue Ruan, Luca Mercuri, Dimitri Papadimitriou, Algirdas Galdikas, Gail Roadknight, Jim Davies, et al. (+4)
3 [GO] 2023―Jan―03 Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature Ana Realista Pedrosa, Diana Cruz Martins, Manfredi Rizzo, José Silva-Nunes
4 [GO] 2022―Dez―05 Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study Michał Kania, Paulina Suduł, Konrad Mazur, Zlata Chaykivska, Mateusz Fiema, Marianna Kopka, et al. (+8)
5 [GO] 2022―Nov―28 Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece Eleftheria Papachristoforou, Stavros Liatis, Ourania Psoma, Aikaterini Kountouri, Vaia Lambadiari, Vasilis Tsimihodimos
6 [GO] 2022―Nov―08 Access to care by medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic John M. Clements
7 [GO] 2022―Aug―13 COVID-19-associated Mucormycosis: A clinico-epidemiological study Jaya Chakravarty, Munesh Kumar Gupta, Ragini Tilak, Rajesh kumar, Rajendra Prasad Maurya, Nilesh Kumar, et al. (+9)
8 [GO] 2022―Feb―07 Covid-19: A new cause of “provoked” A-β+ Ketosis-Prone Diabetes Ruchi Gaba, Ashok Balasubramanyam
9 [GO] 2022―Feb―04 Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes Sara J. Cromer, Caitlin Colling, Daria Schatoff, Michael Leary, Maria I. Stamou, Daryl J. Selen, et al. (+2)
10 [GO] 2021―Dez―09 Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): A prospective study from Eastern India Riddhi Das Gupta, Avica Atri, Sunetra Mondal, Abhishek Bhattacharjee, Ramprasad Garai, Arindam Kumar Hazra, et al. (+4)
11 [GO] 2021―Sep―28 Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions Mônica S.V.M. Silveira, Elizabeth João Pavin, Edimariz Buin Cardoso, Paulo Fanti, Samereh Abdoli
12 [GO] 2021―Mai―28 Preadmission Predictors of Severe COVID-19 in Patients with Diabetes Mellitus Alpana P. Shukla, Beverly G. Tchang, Tiffany Lam, Ian Steller, I.I. Samir Touhamy, Gulce Askin, et al. (+6)
13 [GO] 2021―Apr―19 Pharmacological management of COVID-19 in Type 2 Diabetes Antonio Ceriello, Francesco Prattichizzo
14 [GO] 2021―Jan―20 Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark Kristoffer Panduro Madsen, Ingrid Willaing, Naja Hulvej Rod, Tibor V. Varga, Lene Eide Joensen
15 [GO] 2020―Nov―26 Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus Yangyang Cheng, Ling Yue, Zhiyang Wang, Junxia Zhang, Guangda Xiang
16 [GO] 2020―Nov―26 Impact of obesity on COVID-19 patients Wanqi Yu, Kristen E. Rohli, Shujuan Yang, Peng Jia
17 [GO] 2020―Okt―07 The Early Impact Of The COVID-19 Pandemic On Adults With Type 1 Or Type 2 Diabetes: A National Cohort Study Lawrence Fisher, William Polonsky, Adijat Asuni, Yasmin Jolly, Danielle Hessler
18 [GO] 2020―Okt―07 Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes Ourania Psoma, Eleftheria Papachristoforou, Aikaterini Kountouri, Kostantinos Balampanis, Athena Stergiou, Vaia Lambadiari, et al. (+2)
19 [GO] 2020―Aug―26 Anti-inflammatory properties of antidiabetic drugs: a “promised land” in the COVID-19 era? Niki Katsiki, Ele Ferrannini
20 [GO] 2020―Jul―06 COVID-19 in people living with diabetes: An international consensus A.E. Caballero, A. Ceriello, A. Misra, P. Aschner, M.E. McDonnell, M. Hassanein, et al. (+3)
21 [GO] 2020―Jun―29 Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes Qianhui Zhang, Yanhong Wei, Min Chen, Qianqian Wan, Xiaoqi Chen
22 [GO] 2020―Mai―22 COVID-19 and diabetes: The why, the what and the how Sarah Cuschieri, Stephan Grech
23 [GO] 2020―Mai―15 COVID-19 and diabetes: No time to drag our feet during an untimely pandemic Ioannis Kyrou, Tim Robbins, Harpal S. Randeva
24 [GO] 2020―Mai―14 Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China Fenghua Tao, Xiaoyan Tang, Hai Tao, Yue Luo, Hui Cao, Wei Xiang, et al. (+2)
 [1] 

24 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec